1. To defi ne and describe the clinical syndrome of new-onset refractory status epileptics (NORSE);
2. To discuss the diagnostic and therapeutic approach to NORSE; and
3. To explore the potential role for early immunotherapy in the management of NORSE


Session date: 
12/21/2017 - 3:00pm to 4:00pm CST
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Raisa Martinez MD